305.1 Early surgical complications in pediatric kidney transplantation may impact first year mortality and reduce graft function - a multi-center investigation from the Nordic Paediatric Renal Transplantation Study Group (NPRTSG)
Felicia Kjaernet, Sweden
305.2 Utility of donor-derived cell-free DNA and tacrolimus variability in monitoring early post-kidney transplant outcomes
Dr. Rohit George, United States
305.3 Utilization of Kidneys from Pediatric Donors with Acute Kidney Injury into Pediatric Kidney Transplant Recipients: A Single-center Experience
Dr. Qiang Zhang, People's Republic of China
305.4 Normalizing the percent donor derived cell free DNA (dd-cfDNA) to recipient body surface area (BSA) or to donor to recipient BSA ratio: effects on the diagnostic performance in detecting acute transplant rejection
Dr. Raja Dandamudi, United States
305.5 Belatacept outcomes in pediatric kidney transplantation in France
Dr. Charlotte Duneton, France
305.6 Proteinuria in pediatric kidney transplantation – influencing factors and impact on GFR